The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

BT will continue working with skills group if it drops Prince Andrew as patron

Wed, 20th Nov 2019 10:30

LONDON, Nov 20 (Reuters) - Britain's BT has told a
company promoting digital skills to drop Prince Andrew as a
patron if it wants to keep receiving support from the country's
biggest broadband provider.

Several major companies have sought to distance themselves
from the British royal since he gave a disastrous television
interview on Saturday discussing his friendship with Jeffrey
Epstein.

BT said on Wednesday it was reviewing its work with iDEA.
"In light of recent developments we are reviewing our
relationship with the organisation and hope that we might be
able to work further with them, in the event of a change in
their patronage."

In Britain, royal patronage is usually considered an honour
and a boost for charities.
(Reporting by Kate Holton, editing by Estelle Shirbon)

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.